Foghorn Therapeutics (FHTX) Non-Current Assets (2019 - 2026)

Foghorn Therapeutics' Non-Current Assets history runs 8 years deep, the most recent figure standing at $34.1 million for Q1 2026.

• In Q1 2026, Non-Current Assets rose 2.49% year-over-year to $34.1 million; the TTM figure through Mar 2026 stood at $112.2 million (down 21.95% YoY), while the FY2025 annual figure was $34.9 million, up 1.42% from the prior year.
• Non-Current Assets was $34.1 million for Q1 2026 at Foghorn Therapeutics, down from $34.9 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $58.5 million in Q1 2022 to a low of $20.8 million in Q3 2025.
• Historically, Non-Current Assets has averaged $42.3 million across 5 years, with a median of $43.5 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Non-Current Assets slumped 43.87% in 2025, then grew 2.49% in 2026.
• A 5-year view of Non-Current Assets shows it stood at $53.5 million in 2022, then declined by 14.49% to $45.7 million in 2023, then declined by 24.83% to $34.4 million in 2024, then gained by 1.42% to $34.9 million in 2025, then fell by 2.19% to $34.1 million in 2026.
• The last three Non-Current Assets figures came in at $34.1 million (Q1 2026), $34.9 million (Q4 2025), and $20.8 million (Q3 2025), per Business Quant data.